Jeffrey David Katz, EVP and Chief Legal Officer at RadNet (NASDAQ:RDNT), disclosed an insider sell on June 11, according to a recent SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Katz sold 16,400 shares of RadNet. The total transaction amounted to $1,004,664.
Monitoring the market, RadNet's shares down by 0.0% at $61.13 during Wednesday's morning.
All You Need to Know About RadNet
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments; The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures, and Artificial Intelligence segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company derives a majority of its revenue from the Imaging center segment.
RadNet: A Financial Overview
Revenue Growth: RadNet's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2024, the company achieved a revenue growth rate of ...